CareDx - CDNA Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CDNA shares.
View CDNA analyst ratings or view top-rated stocks.

4 equities research analysts have issued 1-year price objectives for CareDx's shares. Their CDNA share price forecasts range from $26.00 to $87.00. On average, they expect the company's share price to reach $46.20 in the next twelve months. This suggests a possible upside of 249.5% from the stock's current price.
View analysts price targets for CDNA or view top-rated stocks among Wall Street analysts.

CareDx's stock was trading at $45.48 at the start of the year. Since then, CDNA stock has decreased by 70.9% and is now trading at $13.22.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CDNA earnings forecast.

CareDx, Inc (NASDAQ:CDNA) released its quarterly earnings data on Thursday, October, 28th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.21. The business earned $75.60 million during the quarter, compared to analyst estimates of $74.11 million. CareDx had a negative net margin of 23.36% and a negative trailing twelve-month return on equity of 16.51%. The company's revenue was up 41.6% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.06) earnings per share.

CareDx issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $320.00 million-$325.00 million, compared to the consensus revenue estimate of $327.79 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

CareDx's stock is owned by many different retail and institutional investors. Top institutional investors include ARK Investment Management LLC (10.83%), Vanguard Group Inc. (9.46%), State Street Corp (7.93%), BlackRock Inc. (7.49%), Bellevue Group AG (4.86%) and Sumitomo Mitsui Trust Holdings Inc. (4.65%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends.

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDNA stock can currently be purchased for approximately $13.22.

CareDx (NASDAQ:CDNA) has a market capitalization of $707.80 million and generates $296.40 million in revenue each year. The company earns $-30,660,000.00 in net income (profit) each year or ($1.41) on an earnings per share basis.

The company employs 633 workers across the globe.

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.